Tenet Healthcare (NYSE: THC) reported Q2 EPS of $6.12, $1.89 better than the analyst estimate of $4.23. Revenue for the quarter came in at $5.63 billion versus the consensus estimate of $5.43 billion.

2026 Outlook:-
Revenue between $21.9 billion to $22.5 billion vs consensus $21.98.
EPS between $20.30 to $21.69 vs consensus $18.12.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.